$615 Million is the total value of Aviva Holdings Ltd.'s 7 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRTX | MIRATI THERAPEUTICS INC | $460,015,000 | -17.1% | 3,135,966 | 0.0% | 74.86% | -4.4% | |
INSG | INSEEGO CORP | $120,357,000 | -12.5% | 20,647,979 | 0.0% | 19.58% | +0.9% | |
PAM | Buy | PAMPA ENERGIA S Asponsored adr lvl i | $22,571,000 | +610.0% | 1,069,230 | +487.6% | 3.67% | +718.0% |
INSEEGO CORPnote 3.250% 5/0 | $11,307,000 | -12.5% | 24,456,000 | 0.0% | 1.84% | +1.0% | ||
TANGO THERAPEUTICS INC | $295,000 | -15.5% | 26,961 | 0.0% | 0.05% | -2.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Braslyn Ltd. #1
- Golden Harbor Ltd. #2
- Shelton Ventures Inc. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 100.0% |
INSEEGO CORP | 21 | Q3 2023 | 39.6% |
INSEEGO CORP | 14 | Q3 2023 | 10.2% |
PAMPA ENERGIA SA ADR | 12 | Q3 2022 | 26.0% |
MEDICINES CO | 11 | Q3 2019 | 87.4% |
ESPERION THERAPEUTICS INC NE | 9 | Q1 2019 | 14.2% |
TANGO THERAPEUTICS INC. | 9 | Q3 2023 | 0.2% |
SOLID BIOSCIENCES INC. | 9 | Q2 2020 | 0.1% |
INSEEGO CORP | 8 | Q1 2020 | 41.4% |
MACROGENICS INC. | 6 | Q4 2018 | 10.0% |
View Aviva Holdings Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Aviva Holdings Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.